Vice Provost for Graduate Education, Clinical Operations and Research, & Assessment
Newman Hall 230 G
Marc Gillespie is the Vice Provost for Graduate Education, Clinical Operations and Research, and Assessment and serves as a senior staff member in the Office of the Provost.
He earned his doctorate in Oncological Sciences from the University of Utah in 1998, was a research fellow at Memorial Sloan Kettering Cancer Center, and joined St. John’s faculty in the Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, in 2000. He steered successful professional program accreditation self-study reports, chaired, and led college-wide assessment. In 2017, he became the Associate Dean of Graduate Education, Research, and Assessment in the College of Pharmacy and Health Sciences, developing statistical approaches to student performance prediction, accreditation, program development, and curriculum assessment.
Marc currently Chairs the University’s Institutional Biosafety Committee and Graduate Council, and is Co-chair of the University Assessment Committee. In addition, he created and directs the University’s Clinical Venture Laboratory, a New York State Department of Health CLIA compliant laboratory that processes COVID-19 tests administered on campus.
He is a molecular biologist, bioinformaticist, and toxicologist, leading a research group working in pharmacogenomics biomarker discovery. He has published more than 150 research papers on topics including molecular toxicology, RNA biology, and SARS-CoV-2 pathway curation and is an Adjunct Professor in the Department of Biochemistry and Molecular Pharmacology at the NYU Langone Health New York University Grossman School of Medicine. Marc is also a Biocurator and Editor on the Reactome project, an open-source, open-access, manually curated, and peer-reviewed biological pathway database supported by the National Institutes of Health and the European Molecular Biology Laboratory.
Marc leads a research group focused on toxicogenomics, bioinformatics, and biomarker discovery and has taught courses in pharmacogenomics, public health, human anatomy & physiology, toxicogenomics, and molecular biology and has experience in academia and industry related to public health policy.